Status:
COMPLETED
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Radiofrequency Microneedling for Facial Rejuvenation
Lead Sponsor:
Revision Skincare
Conditions:
Photoaging
Wrinkle
Eligibility:
FEMALE
35-65 years
Phase:
NA
Brief Summary
This randomized, single-center, double-blinded, controlled, clinical trial was conducted to investigate the tolerability, safety, and efficacy of a post-procedure cream when used immediately after rad...
Detailed Description
This randomized, single-center, double-blinded, controlled, clinical trial was conducted to investigate the tolerability, safety, and efficacy of a post-procedure cream when used immediately after rad...
Eligibility Criteria
Inclusion
- Female subjects must be between 35-65 years of age.
- Female subjects of childbearing potential must be willing to use a form of birth control during the study.
- Subjects with Fitzpatrick I-VI photo skin type.
- Subjects must have moderate photodamage (Grade II or III) using the Glogau Scale of Photoaging.
- 6\. Subjects interested in Radiofrequency Microneedling treatments. 7. Subjects must have no skin disease in the facial area being evaluated. 8. Subjects must have no known medical conditions that, in the investigator's opinion, may interfere with study participation. 9. Subjects must be wiling to discontinue all active topical facial products and must only use the assigned study products to the face and neck for the duration of the study.
Exclusion
- Subjects being or planning to become pregnant or breastfeeding during the study
- Having received a chemical peel, dermabrasion or microneedling treatment in the previous six months; laser resurfacing (ablative, non-ablative) in the previous twelve months
- Unwilling to refrain from pain medications post-procedure
- Unwilling to discontinue topical anti-aging facial products for one week prior to study commencement or on prescription strength retinoids or skin lightening produces within two months of the study.
- Subjects who have a Glogau Score of I or IV.
Key Trial Info
Start Date :
July 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 23 2022
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT06157853
Start Date
July 11 2022
End Date
August 23 2022
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tennessee Clinical Research Center
Nashville, Tennessee, United States, 37215